What You Should Know:
- SRI Ventures spin-off CurieAI announces the launch of
its AI-driven COVID-19 case management platform
- The Curie solution has been deployed to monitor
inpatients and outpatients at San Carlos Apache Healthcare Corporation (SCAHC).
CurieAI, a Menlo
Park, CA-based healthcare startup spun-off from SRI
Ventures, the corporate venture arm of SRI International, today announced
the release of CurieAI’s first-of-its-kind AI-driven
platform specifically designed for
Read More
Biomarkers| Big Data| News, Analysis, Insights - HIT Consultant
Mission Bio Lands $70M to Expand Cancer Therapies With Single-Cell Multi-Omics Platform
What You Should Know:
- Mission Bio raises $70 million in Series C funding led by
Novo Growth to accelerate the development of cancer therapies with single-cell multi-omics.
- Mission Bio’s Tapestri Platform, the first single-cell platform capable of detecting DNA and protein changes simultaneously, gives a profound insight into the mutations that drive disease to accelerate the development of novel treatments and save patient lives.
Mission Bio,
Inc., a South San Francisco,
Read More
4 Ways Businesses Will Adapt Their Healthcare Landscape
The coronavirus pandemic has affected every aspect of our lives, from how we work to how we get our health care. The crisis has put the creativity of many small businesses to the test after being forced to move operations online once social distancing became the norm. As economies reopen, many aspects of our life that changed in response to the virus will likely return to the way they were.
However, we have the opportunity to emerge stronger from this crisis if the salient shortcomings from
Read More
Cleveland Clinic Awarded $7.2M NIH Grant for to Study MRI-Based Biomarker in Multiple Sclerosis
What You Should Know:
- Cleveland Clinic-led research team has been awarded a $7.2M grant from the National Institutes of Health (NIH) to support a multi-center study to study CVS, an MRI-based biomarker identified in multiple sclerosis associated white matter lesion.
- The prospective study, referred to as CAVS-MS, will
enroll 400 patients with typical or atypical presentations of MS at 11
participating centers in North America, with Cleveland Clinic serving as
Read More
Non-Invasive Technology for Measuring & Monitoring Liver Fat
As part of the growing awareness about chronic disease, it’s important to understand the relationship between nonalcoholic fatty liver disease (NAFLD), an asymptomatic condition characterized by elevated levels of fat in the liver, and diabetes. As a common complication of Type 2 diabetes and obesity, NAFLD can be overlooked comorbidity.
Diabetes is one of the leading causes of disability and death in the United States. One in 10 Americans have diabetes – more than 30 million people – and
Read More
Machine Learning Will Transform Medicine, but Only if We Use it Right
World chess champion Garry Kasparov made headlines all over the world in 1997 for something that he probably wasn’t very excited about. He lost a chess match. To a computer.
It was an IBM supercomputer called Deep Blue and its victory in that New York City match marked the first time a reigning world chess champion had been defeated by a computer under tournament conditions. It was also a symbolically significant event, the first sign that artificial intelligence could become equal to or even
Read More
AiCure Launches Platform to Remotely Capture Digital Biomarkers in Clinical Trials
What You Should Know:
- AiCure launches digital biomarker platform to remotely detect subtle changes in a patient's condition, leverages computer vision and AI to gather and analyze visual and auditory cues directly through the patient's smartphone camera.
- AiCure appoints Ed Ikeguchi, M.D. as its Chief Executive Officer (CEO) to advance AiCure's commitment to improving holistic health through an understanding of the science behind human responses to illness and treatment.
AiCure,
Read More
Biofourmis Acquires Digital Therapeutics Oncology Startup Gaido Health
What You Should Know:
- Boston-based digital therapeutics startup Biofourmis acquires LA-based Gaido Health from Takeda Pharmaceuticals, in a strategic deal that expands Biofourmis’ portfolio in the oncology space.
- Gaido Health—a digital therapeutics company focused on the oncology market—was part of Takeda Digital Ventures, Takeda’s corporate technology investment and incubation arm.
- With Gaido Health’s and Biofourmis’ dual focus on remote monitoring with wearables
Read More
One Drop Acquires Sano’s Continuous Glucose Sensing Platform
What You Should Know:
- One Drop has acquired all the assets and intellectual property of Sano Intelligence, Inc. which include Sano's continuous glucose sensing platform.
- One Drop will leverage the acquired assets, including silicon-sensing production infrastructure, to design, produce, and commercialize a painless, silicon-based continuous health sensing platform for use across multiple conditions.
One Drop, a New York
City-based provider of digital care solutions for people
Read More
Analysis: Applying AI in the Fight Against The Coronavirus
Drug discovery is a notoriously long, complex and expensive process requiring the concerted efforts of the world’s brightest minds. The complexity in understanding human physiology and molecular mechanisms is increasing with every new research paper published and for every new compound tested. As the world is facing a new challenge in trying to both adapt to and defend itself against the coronavirus, artificial intelligence is offering new hope that a cure might be developed faster than ever
Read More